Monday, October 14, 2019
News
NEWS HOME
»
PRESS RELEASES

SpeeDx and Cepheid Announce Test Partnership
  SocialTwist Tell-a-Friend  
   


Date: 16-04-2019 3:51PM
Source: SpeeDx
Category: General, Financial Analyst & Investors, Healthcare & Biotechnology, Pharmaceutical, Manufacturing Companies
Location: Sydney, Australia

Business Wire India

SpeeDx Pty, Ltd. announced an agreement with Cepheid to manufacture their market-leading ResistancePlus® tests for use on the GeneXpert System. The first test in Cepheid’s FleXible Cartridge programme, planned for launch early 2019, is ResistancePlus® MG, detecting the sexually transmitted infection (STI) Mycoplasma genitalium (Mgen) and markers associated with azithromycin resistance.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190415005919/en/

ResistancePlus MG will be the first assay available through the Cepheid FleXible for GeneXpert progr ...

ResistancePlus MG will be the first assay available through the Cepheid FleXible for GeneXpert program.

“The availability of ResistancePlus MG in a FleXible cartridge that runs on the GeneXpert System is a compelling and exciting extension for us,” said Colin Denver, CEO of SpeeDx. “Patients are already benefiting from Resistance Guided Therapy with our central lab tests. Now clinicians can receive resistance information even faster, to support antimicrobial stewardship and more effective antibiotic treatment decisions.”

“Our new FleXible Cartridge program allows Trusted Reagent Manufacturers to develop targeted molecular tests using Cepheid’s easy-to use-cartridge.” said David H. Persing, M.D., Ph.D., Cepheid's Chief Medical and Technology Officer. “With a global installed base of nearly 22,000 GeneXpert Systems, this technology could potentially be applied in multiple settings in which actionable treatment information is needed quickly.”

Management guidelines for Mgen infection include resistance testing1-3 in response to rising rates of macrolide resistance observed with Mgen detection-only or empiric Mgen treatment.4-6 ResistancePlus® MG supports Mgen management guidelines and allows for Resistance Guided Therapy, which is clinically proven to improve cure rates by providing clinicians with much needed information to guide antibiotic treatment.3

About Mgen

M. genitalium can cause symptoms such as urethritis, cervicitis, endometritis and pelvic inflammatory disease. In recent studies, it has been found to have a higher prevalence than gonorrhea. 7 Like gonorrhea, M. genitalium is also evolving into a so-called STI superbug that is becoming resistant to many antibiotic treatments, leading to exceedingly difficult-to-treat infections and threatening global public health.8

Macrolide antibiotics, specifically azithromycin, are the first-line treatment for the rapidly growing problem of M. genitalium STIs, but resistance to these antibiotics has increased up to 50% in several countries.4-6 Due to this growing antibiotic resistance problem, several global STI Management Guidelines on Mgen Infections recommend complementing the use of molecular testing to detect M. genitalium with an assay capable of detecting macrolide resistance-associated mutations.1-3

Currently, there is no FDA-cleared molecular diagnostic test for the detection of M. genitalium in the U.S. The SpeeDx ResistancePlus® MG assay is CE marked for sale in Europe and TGA approved for sale in Australia. The test provides valuable detection and antibiotic resistance information to clinicians in a rapid time frame. Timely detection of antibiotic resistant infections enables Resistance Guided Therapy for better treatment of the disease for patients, lessening the potential for spreading among vulnerable populations and combating antibiotic resistance.

About SpeeDx

Founded in 2009, SpeeDx is an Australian-based private company with offices in London and the US, and distributors across Europe. SpeeDx specializes in molecular diagnostic solutions that go beyond simple detection to offer comprehensive information for improved patient management. Innovative real-time polymerase chain reaction (qPCR) technology has driven market-leading multiplex detection and priming strategies. Product portfolios focus on multiplex diagnostics for sexually transmitted infection (STI), antibiotic resistance markers, and respiratory disease. For more information on SpeeDx please see: https://plexpcr.com

About Cepheid

Based in Sunnyvale, Calif., Cepheid is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company's solutions deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and genetic-based diseases. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer. For more information, visit www.cepheid.com.

1. Jensen JS, Cusini M, Gomberg M, Moi H. 2016. 2016 European guideline on Mycoplasma genitalium infections. J Eur Acad Dermatol Venereol. PMID: 27505296.
2. https://www.bashhguidelines.org/media/1146/ngu-update-05_2017-final.pdf
3. http://www.sti.guidelines.org.au/sexually-transmissible-infections/mycoplasma-genitalium
4. Read T R H, Fairley C K, Murray G L, et al. Outcomes of resistance-guided sequential treatment of Mycoplasma genitalium infections: a prospective evaluation, Clinical Infectious Diseases, ciy477, https://doi.org/10.1093/cid/ciy477
5. Getman D, Jiang A, O'Donnell M, Cohen S. 2016. Mycoplasma genitalium prevalence, coinfection, and macrolide antibiotic resistance frequency in a multicenter clinical study cohort in the United States. J Clin Microbiol 54:2278-2283.
6. Murray GL, Bradshaw CS, Bissessor M, et al. Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium. Emerging Infectious Diseases. 2017;23(5):809-812. doi:10.3201/eid2305.161745.
7. Miller WC, Ford CA, Morris M, et al. Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA 2004; 291:2229–2236.
8. Unemo, M. & Jensen, J.S. ‘Antimicrobial-resistant sexually transmitted infections: gonorrhoea and Mycoplasma genitalium’. 2016. Nat. Rev. Urol.268. Published online 10 Jan 2017. doi:10.1038/nrurol


MULTIMEDIA AVAILABLE :
https://www.businesswire.com/news/home/20190415005919/en/


CONTACTS :

SpeeDx:
Europe, Australia, New Zealand:
Madeline O’Donoghue
+61 2 9209 4170
madelineo@speedx.com.au

USA:
Rick Roose
+1 415.202.4445
roi.roose@gmail.com

Cepheid:
Darwa Peterson
darwa@cepheid.com
Tel. + 1.408.400.4324

More Press Releases

Peter Sharp Resigns as President of Taubman Asia; Paul Wright to be Promoted into Role

HKTDC Hong Kong International Wine & Spirits Fair 2019

IMA (Institute of Management Accountants) Celebrates 100 Years at Middle East and India Regional Conference

Celebrate a Safe Diwali With Firecracker Insurance From Bajaj Finserv

Second Batch of Advanced Data Science Program by IMT CDL and EY to Commence From October 2019

Introducing Chhaa Jaa, Girl Effect’s First Youth Programme in India

CyberEye to Organize Asia’s Largest Conference in LoRaWAN - The Things Conference India

Merck Foundation Partners With the Gambian Government to Build Healthcare Capacity in the Country

Zindagi Ka Lutf Uthao – SonyLIV’s New Short Film ‘LUTF’, Teaches Us to Live Life to the Fullest

Prestige Group Unveils the 4th Edition of KEYS – Their Much-Awaited Property Expo

Broadcom Inc. is the New National Sponsor of the IRIS Fair

Yokogawa Releases Dynamic Real Time Optimizer, a New Solution in the OpreX Asset Operations and Optimization Family

Dell Technologies Launches OptiPlex 7070 Ultra - the World’s Most Flexible, Modular Zero-Footprint PC in India

Eupheus Learning and Pickatale Bring Famous Classics to Life

HelpSystems’ Accelerating Growth Attracts Strategic Investment from TA Associates and Charlesbank Capital Partners

This World Sight Day, Avail the Best Treatment for Your Eyes With Bajaj Finserv’s LifeCare Finance

Deltix Announces CryptoCortex Integration with MPC-wallet Provider Curv

Fashion Start-up Urbanic Redefines ‘The Ideal Body’ Trend With a Body Positivity Campaign

GoDaddy Launches New Websites + Marketing Product to Help Indian Entrepreneurs Look Great Everywhere Online That Matters

Corporate Social Responsibility Related News Releases and Story Ideas for Reporters, Bloggers and Media Outlets

PMI Sets Carbon Neutrality Target for All of Its Factories By 2030

J Mitra & Co Awarded India’s Greatest Brand Award at the Asian Business & Social Summit 2019

Sony Pictures Networks India Supports ‘Govt. Schools Get ‘Smart’ With Its CSR Programme ‘YAY! Vidya’

Galderma Advances Phase 3 Clinical Study with Nemolizumab in Moderate-to-Severe Atopic Dermatitis

Vidyashilp Academy Heads to Yale for World Scholar's Cup

Tej Kohli Foundation advocates a scalable, accessible and affordable technology solution to end corneal blindness worldwide.

The Activity of Seeking and Selecting My Favorite Yunnan Tourist Scenic Areas was Closed

FAA Approves AerTrak for Boeing 777-200 Series Aircraft to Comply with Automatic Dependent Surveillance-Broadcast (ADS-B) Operations Mandate

NIPPON Platform Has Won the ‘Audience Award’ at the Mastercard Start Path Japan Selection Day Held in Japan for the First Time

4 Crore Jobs to Be Created in Healthcare Industry by 2020: Rxcruit Advisors

Trivest Partners Announces Quatrro Business Support Services, a New TGIF Platform Investment

ABB Demonstrates Concept of Mobile Laboratory Robot for Hospital of the Future

Mouser Electronics and Grant Imahara Explore Prototype Design with Arduino in Latest “Engineering Big Ideas” Series Video

Murata to Develop Millimeter-Wave (60 GHz) RF Module for Terragraph

Perspectum announces partnership with Precious Medical Centre

 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
INDIA WORLD ASIA
MP political circles abuzz after Scindia...
Those in power in Hry will be in Opposit...
We enjoy freedom living in India, says T...
Modi crosses 30 million followers on Ins...
Expulsion of six varsity students who wr...
Sourav Ganguly set to be new BCCI Presid...
More...    
 
 Top Stories
Pressing lotus symbol means droppin... 
Vice President Naidu interacts with... 
HAL braces for staff strike over wa... 
Dutch royals on five day state visi... 
'Nirbhaya's friend took money from ... 
Kerala fails to get medics from res... 
UP: Five detained for thrashing man... 
New Delhi: Crime Branch arrests thr...